Jung Su Ryu

693 total citations
25 papers, 570 citations indexed

About

Jung Su Ryu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jung Su Ryu has authored 25 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Oncology. Recurrent topics in Jung Su Ryu's work include Connective tissue disorders research (10 papers), Cancer therapeutics and mechanisms (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Jung Su Ryu is often cited by papers focused on Connective tissue disorders research (10 papers), Cancer therapeutics and mechanisms (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Jung Su Ryu collaborates with scholars based in United States, South Korea and Croatia. Jung Su Ryu's co-authors include Dražen Raucher, Hyun Joon Lee, P. J. S. Vig, Lacey R. McNally, Uy Dong Sohn, Young‐Soo Hong, Eddie Perkins, Michael E. Hall, Chung‐Kyu Ryu and Leslie A. Robinson and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Jung Su Ryu

24 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung Su Ryu United States 13 356 141 85 80 66 25 570
Neelesh Soman United States 9 236 0.7× 79 0.6× 79 0.9× 69 0.9× 118 1.8× 12 570
Junxiao Ye China 17 516 1.4× 229 1.6× 58 0.7× 176 2.2× 42 0.6× 23 864
Jessica R. Vargas United States 7 556 1.6× 115 0.8× 106 1.2× 59 0.7× 69 1.0× 7 711
Gloria Ruiz‐Gómez Germany 13 447 1.3× 127 0.9× 44 0.5× 63 0.8× 35 0.5× 33 797
Katri Rosenthal-Aizman Sweden 5 423 1.2× 125 0.9× 41 0.5× 36 0.5× 94 1.4× 6 512
Julien Ogier Ireland 16 525 1.5× 315 2.2× 69 0.8× 150 1.9× 63 1.0× 23 869
Benjamí Oller‐Salvia Spain 12 648 1.8× 244 1.7× 52 0.6× 133 1.7× 74 1.1× 27 975
Joëlle Saulnier France 14 306 0.9× 42 0.3× 68 0.8× 81 1.0× 69 1.0× 34 567
Nicholas Flynn United States 12 279 0.8× 79 0.6× 50 0.6× 62 0.8× 50 0.8× 17 422
Angela Alexander-Bryant United States 11 318 0.9× 199 1.4× 59 0.7× 132 1.6× 15 0.2× 18 544

Countries citing papers authored by Jung Su Ryu

Since Specialization
Citations

This map shows the geographic impact of Jung Su Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Su Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Su Ryu more than expected).

Fields of papers citing papers by Jung Su Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Su Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Su Ryu. The network helps show where Jung Su Ryu may publish in the future.

Co-authorship network of co-authors of Jung Su Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Su Ryu. A scholar is included among the top collaborators of Jung Su Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Su Ryu. Jung Su Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cora, Elsa M., et al.. (2022). Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells. Biochemistry and Biophysics Reports. 31. 101326–101326. 2 indexed citations
2.
Ryu, Jung Su, et al.. (2022). Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity. Molecules. 27(11). 3371–3371. 12 indexed citations
3.
Ryu, Jung Su, Felix Kratz, & Dražen Raucher. (2021). Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study. International Journal of Molecular Sciences. 22(3). 1126–1126. 10 indexed citations
4.
Ryu, Jung Su, et al.. (2017). Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of drug targeting. 25(6). 523–531. 23 indexed citations
5.
Ryu, Jung Su & Dražen Raucher. (2017). Abstract 5129: Cell-penetrating doxorubicin released from Elastin-like polypeptide kills doxorubicin-resistant cancer cells. Cancer Research. 77(13_Supplement). 5129–5129. 2 indexed citations
6.
Raucher, Dražen & Jung Su Ryu. (2015). Cell-penetrating peptides: strategies for anticancer treatment. Trends in Molecular Medicine. 21(9). 560–570. 190 indexed citations
7.
Ryu, Jung Su, et al.. (2015). Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy. Molecules. 20(12). 21750–21769. 87 indexed citations
8.
Ryu, Jung Su, et al.. (2014). Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer. Drug Design Development and Therapy. 8. 1649–1649. 18 indexed citations
9.
Ryu, Jung Su & Dražen Raucher. (2014). Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications. Expert Opinion on Drug Delivery. 12(4). 653–667. 29 indexed citations
10.
Ryu, Jung Su & Dražen Raucher. (2014). Elastin-like polypeptides: The influence of its molecular weight on local hyperthermia-induced tumor accumulation. European Journal of Pharmaceutics and Biopharmaceutics. 88(2). 382–389. 26 indexed citations
11.
Ryu, Jung Su & Dražen Raucher. (2014). Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine. Cancer Letters. 348(1-2). 177–184. 31 indexed citations
12.
Park, Sun Young, et al.. (2008). Relaxation Effect of Synthetic Ceramide Analogues in Cat Esophageal Smooth Muscle Cells. Korean Journal of Physiology and Pharmacology. 12(4). 137–137. 4 indexed citations
13.
Lee, Kyeong, Jung Su Ryu, Yinglan Jin, et al.. (2007). Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites. Organic & Biomolecular Chemistry. 6(2). 340–348. 29 indexed citations
14.
Lee, Dong Kyu, Sun Young Park, Chang Yell Shin, et al.. (2007). Effect of hydrogen peroxide on VIP-induced relaxation of the cat lower esophageal sphincter. Archives of Pharmacal Research. 30(11). 1419–1425. 2 indexed citations
15.
Lee, Hong Sub, Jung Su Ryu, Young‐Soo Hong, et al.. (2006). Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models. Cancer Chemotherapy and Pharmacology. 60(2). 197–201. 6 indexed citations
16.
Ryu, Jung Su, et al.. (2006). Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt. Bioorganic & Medicinal Chemistry Letters. 16(23). 6001–6005. 22 indexed citations
17.
Kwon, Oh‐Seung, Young‐Soo Hong, Jung Joon Lee, et al.. (2005). Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats. Archives of Pharmacal Research. 28(4). 476–482. 2 indexed citations
18.
Ryu, Jung Su, Hong Sub Lee, Young‐Soo Hong, et al.. (2005). In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin). Cancer Chemotherapy and Pharmacology. 57(6). 811–818. 7 indexed citations
19.
Kwon, Oh‐Seung, Hong Sub Lee, Jung Su Ryu, et al.. (2005). HPLC Analysis and Pharmacokinetic Characteristics of 11-Hydroxyaclacinomycin X (ID-6105), a Novel Anthracycline, in Rats and Beagle Dogs. Biological and Pharmaceutical Bulletin. 28(4). 688–693. 5 indexed citations
20.
Ryu, Jung Su, et al.. (2001). NMDA receptor and NO mediate ET-1-induced behavioral and cardiovascular effects in periaqueductal gray matter of rats. Archives of Pharmacal Research. 24(1). 64–68. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelesh Soman Breakdown of academic impact, for papers by Junxiao Ye Breakdown of academic impact, for papers by Jessica R. Vargas Breakdown of academic impact, for papers by Gloria Ruiz‐Gómez Breakdown of academic impact, for papers by Katri Rosenthal-Aizman Breakdown of academic impact, for papers by Julien Ogier Breakdown of academic impact, for papers by Benjamí Oller‐Salvia Breakdown of academic impact, for papers by Joëlle Saulnier Breakdown of academic impact, for papers by Nicholas Flynn Breakdown of academic impact, for papers by Angela Alexander-Bryant
Rankless by CCL
2026